Literature DB >> 7836842

Testing the role of p53 in the expression of genetic instability and apoptosis in ataxia-telangiectasia.

M S Meyn1, L Strasfeld, C Allen.   

Abstract

We have obtained initial evidence supporting a new model for the human disease ataxia-telangiectasia (A-T), in which the A-T and p53 genes play crucial roles in a signal transduction network that activates multiple cellular functions in response to DNA damage. Three of the model's predictions were tested. (1) Disrupting cell cycle checkpoints should increase spontaneous rates in normal cells. In order to interfere with the G1/S checkpoint, we transfected a normal cell line with vectors expressing either a dominant-negative p53ala143 mutant or a human papilloma virus E6 gene. These transformants showed 10-80-fold elevations in spontaneous recombination rates when compared with their parent. (2) A-T cells should be sensitive to DNA damage-induced apoptosis. Widespread apoptosis was detectable in four A-T fibroblast lines, but not two control lines, beginning 24 h after exposure to X-rays or streptonigrin, but not UV. Streptonigrin also induced widespread apoptosis in A-T lymphoblasts but not in control lymphoblasts. (3) Disruption of p53 function in A-T cells should increase their mutagen resistance by interfering with apoptosis. Stable transfection of either the p53143ala or the HPV18 E6 construct was associated with acquisition of streptonigrin and radiation resistance, while transfection with the p53143ala construct did not affect the streptonigrin sensitivity of a control cell line.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7836842

Source DB:  PubMed          Journal:  Int J Radiat Biol        ISSN: 0955-3002            Impact factor:   2.694


  10 in total

1.  The yeast TEL1 gene partially substitutes for human ATM in suppressing hyperrecombination, radiation-induced apoptosis and telomere shortening in A-T cells.

Authors:  E Fritz; A A Friedl; R M Zwacka; F Eckardt-Schupp; M S Meyn
Journal:  Mol Biol Cell       Date:  2000-08       Impact factor: 4.138

Review 2.  Role of protein kinase activity in apoptosis.

Authors:  M F Lavin; D Watters; Q Song
Journal:  Experientia       Date:  1996-10-31

Review 3.  [Significance of apoptotic processes in radiotherapy. II].

Authors:  M Abend; D van Beuningen
Journal:  Strahlenther Onkol       Date:  1998-04       Impact factor: 3.621

4.  Localization of the cell death genes CPP32 and Mch-2 to human chromosome 4q.

Authors:  J Nasir; J L Theilmann; V Chopra; A M Jones; D Walker; D M Rasper; J P Vaillancourt; J E Hewitt; D W Nicholson; M R Hayden
Journal:  Mamm Genome       Date:  1997-01       Impact factor: 2.957

Review 5.  Ataxia-telangiectasia and the ATM gene: linking neurodegeneration, immunodeficiency, and cancer to cell cycle checkpoints.

Authors:  Y Shiloh; G Rotman
Journal:  J Clin Immunol       Date:  1996-09       Impact factor: 8.317

6.  Interaction of p53 with the human Rad51 protein.

Authors:  S Buchhop; M K Gibson; X W Wang; P Wagner; H W Stürzbecher; C C Harris
Journal:  Nucleic Acids Res       Date:  1997-10-01       Impact factor: 16.971

7.  Overexpression of a truncated human topoisomerase III partially corrects multiple aspects of the ataxia-telangiectasia phenotype.

Authors:  E Fritz; S H Elsea; P I Patel; M S Meyn
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-29       Impact factor: 11.205

8.  The product of the ataxia-telangiectasia group D complementing gene, ATDC, interacts with a protein kinase C substrate and inhibitor.

Authors:  P M Brzoska; H Chen; Y Zhu; N A Levin; M H Disatnik; D Mochly-Rosen; J P Murnane; M F Christman
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

Review 9.  Cell cycle regulation in response to DNA damage in mammalian cells: a historical perspective.

Authors:  J P Murnane
Journal:  Cancer Metastasis Rev       Date:  1995-03       Impact factor: 9.264

10.  RHAMM splice variants confer radiosensitivity in human breast cancer cell lines.

Authors:  Alexandra Schütze; Christian Vogeley; Tobias Gorges; Sören Twarock; Jonas Butschan; Anna Babayan; Diana Klein; Shirley K Knauer; Eric Metzen; Volkmar Müller; Verena Jendrossek; Klaus Pantel; Karin Milde-Langosch; Jens W Fischer; Katharina Röck
Journal:  Oncotarget       Date:  2016-04-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.